Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John M. Holliman III currently holds 401,343 shares of Capstone Therapeutics Corp. (CAPS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Holliman III has been a net buyer of CAPS stock. They have purchased $135.6K and sold $0 worth of shares.
John M. Holliman III's most recent insider trade was on Aug 7, 2026, when they sold 305,248 shares at $0.00 per share.
John M. Holliman III serves as Executive at Capstone Therapeutics Corp. (CAPS). They have executed 23 insider transactions totaling $135.6K over their tenure at the company.
John M. Holliman III holds the position of Executive at Capstone Therapeutics Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
John M. Holliman III has shown a buying trading pattern, with $135.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John M. Holliman III was on Mar 11, 2008, when they purchased $18.4K worth of OLGC shares. This transaction involved 20,000 shares at $0.92 per share.
John M. Holliman III currently owns 401,343 shares of Capstone Therapeutics Corp. (CAPS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John M. Holliman III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John M. Holliman III has 23 Form 4 filings on record as an insider at Capstone Therapeutics Corp..
Set alerts for John M. Holliman III and 40,000+ other insiders.